海外医薬品不足状況

更新された供給不足状況を示しています。
ある時点での供給不足の全体的状況は「供給関連情報」に定期的にアップします。

米国

カナダ

カナダの情報はありません。

オーストラリア

  • 2024.08.26
    Active ingredientsDosage formQuantity of active ingredientsAvailabilityReasonLast updated
    clarithromycinTablet, film coated250 mgLimited AvailabilityManufacturing23/08/2024
    isosorbide dinitrateTablet, uncoated5 mgAvailableManufacturing23/08/2024
    adrenaline (epinephrine)Injection, solution1 mgLimited AvailabilityManufacturing23/08/2024
    gliclazideTablet, modified release30 mgAvailableManufacturing23/08/2024
    oxazepamTablet, uncoated15 mgUnavailableManufacturing23/08/2024
    OmalizumabInjection, solution150 mgUnavailableManufacturing23/08/2024
    efmoroctocog alfaInjection, powder for250 IUAvailableManufacturing23/08/2024
    timolol maleate~latanoprostEye Drops, solution6.83 mg/mL~50 microgram/mLUnavailableUnexpected increase in consumer demand23/08/2024
    olopatadine hydrochlorideEye Drops1.11 mg/mLUnavailableManufacturing23/08/2024
    temozolomideCapsule, hard5 mgUnavailableManufacturing23/08/2024
    ezetimibeTablet, uncoated10 mgUnavailableManufacturing23/08/2024
    tadalafilTablet, film coated5 mgUnavailableManufacturing23/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgLimited AvailabilityManufacturing23/08/2024
    fenofibrateTablet145 mgAvailableManufacturing23/08/2024
    busulfanInjection, concentrated60 mgUnavailableManufacturing23/08/2024
    letrozoleTablet, film coated2.5 mgAvailableManufacturing23/08/2024
    bendamustine hydrochloride monohydrateInjection, powder for25 mgAvailableUnexpected increase in demand due to other sponsors unable to supply23/08/2024
    difelikefalin acetateInjection, solution55 microgramAvailableManufacturing23/08/2024
    enoxaparin sodiumInjection, solution40 mgReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/08/2024
    enoxaparin sodiumInjection, solution120 mgReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/08/2024
    dexamethasone~framycetin sulfate~gramicidinEar Drops.5 mg/mL~5 mg/mL~.05 mg/mLAvailableManufacturing23/08/2024
    tobramycinInhalation, conventional60 mg/mLUnavailableManufacturing23/08/2024
    pamidronate disodiumInjection, concentrated9 mgAvailableManufacturing23/08/2024
    paclitaxelInjection, concentrated6 mg/mLLimited AvailabilityManufacturing23/08/2024
    ampicillinInjection, powder for1 gReduction in supply until supply is exhaustedCommercial Changes / Commercial viability23/08/2024
    FilgrastimInjection, solution480 microgramLimited AvailabilityTransport / Logistic issues / Storage capacity issues22/08/2024
    metoprolol succinateTablet, modified release95 mgAvailableManufacturing22/08/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgLimited AvailabilityManufacturing22/08/2024
    quetiapine fumarateTablet, film coated115.12 mgAvailableManufacturing22/08/2024
    quetiapine fumarateTablet, film coated345.36 mgUnavailableManufacturing22/08/2024
    prilocaine hydrochloride~felypressinInjection, solution30 mg/mL~.54 microgram/mLAvailableManufacturing22/08/2024
    nizatidineCapsule, hard150 mgUnavailableManufacturing22/08/2024
    ropinirole hydrochlorideTablet, film coated2.28 mgUnavailableManufacturing22/08/2024
    dostarlimabInjection, intravenous infusion500 mg/mLLimited AvailabilityUnexpected increase in consumer demand22/08/2024
    estradiol~norethisterone acetateDrug delivery system, transdermal.512 mg~4.8 mgAvailableManufacturing22/08/2024
    nizatidineCapsule, hard300 mgUnavailableManufacturing22/08/2024
    fentanylDrug delivery system, transdermal4.2 mgUnavailableManufacturing21/08/2024
    fentanylDrug delivery system, transdermal8.4 mgUnavailableManufacturing21/08/2024
    fentanylDrug delivery system, transdermal12.6 mgUnavailableManufacturing21/08/2024
    fentanylDrug delivery system, transdermal16.8 mgUnavailableManufacturing21/08/2024
    fentanylDrug delivery system, transdermal2.1 mgUnavailableManufacturing21/08/2024
    lisdexamfetamine dimesilateCapsule, hard20 mgAvailableUnexpected increase in consumer demand21/08/2024
    cinacalcet hydrochlorideTablet33.064 mgUnavailableManufacturing21/08/2024
    cinacalcet hydrochlorideTablet66.127 mgAvailableManufacturing21/08/2024
    rifampicinCapsule, hard150 mgAvailableManufacturing21/08/2024
    escitalopram oxalateTablet, film coated25.56 mgLimited AvailabilityManufacturing20/08/2024
    amlodipine besilateTablet, uncoated6.94 mgLimited AvailabilityManufacturing20/08/2024
    alendronate sodiumTablet91.37 mgAvailableManufacturing20/08/2024
    galantamine hydrobromideCapsule, modified release20.512 mgUnavailableManufacturing20/08/2024
    FilgrastimInjection, solution120 microgramLimited AvailabilityTransport / Logistic issues / Storage capacity issues20/08/2024
    donepezil hydrochlorideTablet, film coated10 mgAvailableManufacturing20/08/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply20/08/2024
    oxycodone hydrochlorideCapsule, hard10 mgAvailableCommercial Changes / Commercial viability20/08/2024
    oxycodone hydrochlorideCapsule, hard20 mgUnavailableCommercial Changes / Commercial viability20/08/2024
    oxycodone hydrochlorideCapsule, hard5 mgAvailableCommercial Changes / Commercial viability20/08/2024
    gliclazideTablet, modified release30 mgLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply20/08/2024
    Rabies virusInjection, powder for2.5 IUEmergency Supply OnlyManufacturing20/08/2024
    risperidoneOral Liquid, solution1 mg/mLUnavailableManufacturing20/08/2024
    spironolactoneTablet, uncoated100 mgLimited AvailabilityManufacturing20/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgUnavailableManufacturing20/08/2024
    flecainide acetateTablet50 mgUnavailableManufacturing20/08/2024
    indometacinCapsule, hard25 mgLimited AvailabilityManufacturing20/08/2024
    paracetamolTablet, modified release665 mgLimited AvailabilityTransport / Logistic issues / Storage capacity issues20/08/2024
    oxazepamTablet, uncoated30 mgUnavailableManufacturing20/08/2024
    captoprilTablet, uncoated25 mgUnavailableManufacturing20/08/2024
    pravastatin sodiumTablet, uncoated40 mgLimited AvailabilityManufacturing20/08/2024
    morphine hydrochloride trihydrateOral Liquid, solution1 mg/mLUnavailableCommercial Changes / Commercial viability19/08/2024
    morphine hydrochloride trihydrateOral Liquid, solution2 mg/mLUnavailableCommercial Changes / Commercial viability19/08/2024
    morphine hydrochloride trihydrateOral Liquid, solution5 mg/mLUnavailableCommercial Changes / Commercial viability19/08/2024
    Choriogonadotropin alfaInjection, solution250 microgramLimited AvailabilityUnexpected increase in consumer demand19/08/2024
    carmustineInjection, powder for100 mgUnavailableManufacturing19/08/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgUnavailableManufacturing19/08/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgUnavailableManufacturing19/08/2024
    nortriptyline hydrochlorideTablet, uncoated28.5 mgUnavailableManufacturing19/08/2024
    nortriptyline hydrochlorideTablet, uncoated11.4 mgUnavailableManufacturing19/08/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~6.935 mgAvailableManufacturing19/08/2024
    lacosamideTablet, film coated50 mgAvailableManufacturing19/08/2024
    montelukast sodiumTablet, chewable5.2 mgAvailableManufacturing19/08/2024
    montelukast sodiumTablet, chewable4.16 mgAvailableManufacturing19/08/2024
    carbacholInjection, solution100 microgram/mLLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply19/08/2024
    clonazepamTablet, uncoated2 mgAvailableManufacturing19/08/2024
    mianserin hydrochlorideTablet, film coated20 mgAvailableManufacturing19/08/2024
    estradiol hemihydrateDrug delivery system, transdermal1.54 mgAvailableUnexpected increase in demand due to other sponsors unable to supply19/08/2024
    estradiol hemihydrateDrug delivery system, transdermal.77 mgAvailableCommercial Changes / Commercial viability19/08/2024
    estradiol hemihydrateDrug delivery system, transdermal3.09 mgAvailableUnexpected increase in demand due to other sponsors unable to supply19/08/2024
  • 2024.08.20
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    ondansetron hydrochloride dihydrateInjection, solution5 mgCurrentUnavailableManufacturing16/08/2024
    azithromycin dihydrateTablet, film coated524.05 mgAnticipatedAvailableManufacturing16/08/2024
    hydrochlorothiazide~amlodipine besilate~olmesartan medoxomilTablet25 mg~6.944 mg~40 mgCurrentUnavailableManufacturing16/08/2024
    latanoprostEye Drops, solution50 microgram/mLResolvedAvailableUnexpected increase in consumer demand16/08/2024
    acarboseTablet50 mgCurrentUnavailableManufacturing16/08/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues16/08/2024
    cefuroxime axetilTablet, film coated300.715 mgResolvedAvailableUnexpected increase in consumer demand16/08/2024
    paracetamolInjection1 gResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply16/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentLimited AvailabilityManufacturing16/08/2024
    bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution2.64 mg/mL~4.5 microgram/mLResolvedAvailableManufacturing16/08/2024
    cinacalcet hydrochlorideTablet, film coated33 mgCurrentLimited AvailabilityManufacturing16/08/2024
    lanreotide acetateInjection, solution100 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues16/08/2024
    erythromycin ethyl succinateOral Liquid, powder for468 mgAnticipatedAvailableUnexpected increase in consumer demand16/08/2024
    doxorubicin hydrochlorideInjection, concentrated2 mg/mLResolvedAvailableManufacturing16/08/2024
    clindamycin phosphateLotion10 mg/mLAnticipatedAvailableManufacturing16/08/2024
    pamidronate disodiumInjection, concentrated9 mgCurrentLimited AvailabilityManufacturing16/08/2024
    ezetimibeTablet10 mgResolvedAvailableUnexpected increase in consumer demand16/08/2024
    methylphenidate hydrochlorideTablet, modified release36 mgCurrentLimited AvailabilityManufacturing16/08/2024
    povidoneiodineApplication100 mg/mLCurrentLimited AvailabilityManufacturing15/08/2024
    risperidoneTablet, film coated4 mgAnticipatedAvailableManufacturing15/08/2024
    donepezil hydrochlorideTablet, film coated5 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues15/08/2024
    tacrolimus monohydrateCapsule, hard1.022 mgAnticipatedAvailableManufacturing15/08/2024
    valaciclovir hydrochloride monohydrateTablet, film coated611.7 mgDiscontinuedUnavailableCommercial Changes / Commercial viability15/08/2024
    montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing15/08/2024
    sildenafil citrateTablet, film coated28.1 mgCurrentLimited AvailabilityManufacturing15/08/2024
    enalapril maleateTablet10 mgResolvedAvailableManufacturing15/08/2024
    quetiapine fumarateTablet, film coated345.36 mgCurrentUnavailableManufacturing15/08/2024
    temozolomideCapsule, hard5 mgCurrentUnavailableManufacturing15/08/2024
    temozolomideCapsule, hard180 mgResolvedAvailableManufacturing15/08/2024
    rosuvastatin calciumTablet, film coated5.21 mgResolvedAvailableManufacturing15/08/2024
    olmesartan medoxomilTablet40 mgResolvedAvailableManufacturing15/08/2024
    ezetimibeTablet, uncoated10 mgAnticipatedAvailableManufacturing15/08/2024
    irbesartanTablet, film coated150 mgAnticipatedAvailableManufacturing15/08/2024
    hydrochlorothiazide~irbesartanTablet, film coated25 mg~300 mgAnticipatedAvailableManufacturing15/08/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing15/08/2024
    metformin hydrochlorideTablet, film coated850 mgCurrentUnavailableManufacturing15/08/2024
    hydrochlorothiazide~olmesartan medoxomilTablet25 mg~40 mgResolvedAvailableManufacturing15/08/2024
    flecainide acetateTablet50 mgCurrentUnavailableManufacturing15/08/2024
    dasatinibTablet, film coated100 mgCurrentLimited AvailabilityManufacturing15/08/2024
    latanoprostEye Drops, solution.05 mg/mLCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues15/08/2024
    lacosamideTablet, film coated150 mgAnticipatedAvailableManufacturing15/08/2024
    estradiolDrug delivery system, transdermal.39 mgCurrentUnavailableManufacturing15/08/2024
    estradiolDrug delivery system, transdermal.585 mgCurrentUnavailableManufacturing15/08/2024
    estradiolDrug delivery system, transdermal.78 mgCurrentUnavailableManufacturing15/08/2024
    estradiolDrug delivery system, transdermal1.56 mgCurrentUnavailableManufacturing15/08/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated41.6 mg~10 mgCurrentLimited AvailabilityManufacturing15/08/2024
    lidocaine hydrochloride~adrenaline (epinephrine) acid tartrateInjection, solution5 mg/mL~9.1 microgram/mLDiscontinuedUnavailableManufacturing14/08/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityManufacturing14/08/2024
    anidulafunginInjection, powder for100 mgAnticipatedAvailableManufacturing14/08/2024
    adrenaline (epinephrine)Injection, solution1 mgCurrentLimited AvailabilityManufacturing14/08/2024
    efmoroctocog alfaInjection, powder for250 IUCurrentUnavailableManufacturing14/08/2024
    Insulin aspartInjection, solution100 U/mLResolvedAvailableTransport / Logistic issues / Storage capacity issues14/08/2024
    cinacalcet hydrochlorideTablet, film coated66 mgResolvedAvailableManufacturing14/08/2024
    cinacalcet hydrochlorideTablet, film coated99 mgResolvedAvailableManufacturing14/08/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing14/08/2024
    nizatidineCapsule, hard300 mgCurrentUnavailableManufacturing14/08/2024
    Coxiella burnetiiInjection5 microgram/mLCurrentLimited AvailabilityManufacturing13/08/2024
    zolpidem tartrateTablet, film coated10 mgDiscontinuedUnavailableCommercial Changes / Commercial viability13/08/2024
    eprosartan mesilate~hydrochlorothiazideTablet, film coated735.8 mg~12.5 mgDiscontinuedUnavailableManufacturing13/08/2024
    insulinInjection, solution100 IU/mLResolvedAvailableManufacturing13/08/2024
    griseofulvinTablet500 mgCurrentUnavailableManufacturing13/08/2024
    papaverine hydrochlorideInjection, solution12 mg/mLAnticipatedAvailableManufacturing13/08/2024
    clonidine hydrochlorideTablet, uncoated100 microgramAnticipatedAvailableManufacturing13/08/2024
    ropivacaine hydrochlorideInjection, solution400 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues13/08/2024
    olmesartan medoxomil~hydrochlorothiazide~amlodipine besilateTablet40 mg~12.5 mg~6.944 mgResolvedAvailableManufacturing13/08/2024
    capecitabineTablet, film coated500 mgAnticipatedAvailableManufacturing13/08/2024
    adrenaline (epinephrine) acid tartrateInjection, solution182 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply13/08/2024
    codeine phosphate hemihydrate~doxylamine succinate~paracetamolTablet, uncoated10 mg~5.1 mg~500 mgCurrentUnavailableManufacturing13/08/2024
    bosentan monohydrateTablet, film coated64.541 mgCurrentUnavailableManufacturing13/08/2024
    ezetimibeTablet10 mgCurrentUnavailableManufacturing13/08/2024
    cisplatinInjection, concentrated1 mg/mLResolvedAvailableUnexpected increase in consumer demand13/08/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand13/08/2024
    dasatinibTablet, film coated70 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability13/08/2024
    mercaptopurine monohydrateTablet50 mgResolvedAvailableManufacturing13/08/2024
    gefitinibTablet, film coated250 mgCurrentUnavailableProduct recall13/08/2024
    iopromideInjection, solution768.86 mg/mLResolvedAvailableUnexpected increase in consumer demand13/08/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramResolvedAvailableManufacturing13/08/2024
    estradiolDrug delivery system, transdermal1.17 mgCurrentLimited AvailabilityManufacturing13/08/2024
    lanreotide acetateInjection, solution133.33 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues13/08/2024
    dasatinibTablet, film coated50 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply13/08/2024
    tirzepatideInjection, solution5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/08/2024
    tirzepatideInjection, solution7.5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/08/2024
    tirzepatideInjection, solution12.5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/08/2024
    tirzepatideInjection, solution10 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/08/2024
    tirzepatideInjection, solution15 mgCurrentUnavailableUnexpected increase in consumer demand13/08/2024
    tirzepatideInjection, solution2.5 mgCurrentLimited AvailabilityUnexpected increase in consumer demand13/08/2024
    fluticasone propionateInhalation, pressurised125 microgram/actuationAnticipatedAvailableUnexpected increase in consumer demand13/08/2024
    flecainide acetateTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing13/08/2024
    tobramycinInjection, solution80 mgDiscontinuedUnavailableCommercial Changes / Commercial viability12/08/2024
    fentanylDrug delivery system, transdermal7.65 mgDiscontinuedUnavailableCommercial Changes / Commercial viability12/08/2024
    fentanylDrug delivery system, transdermal1.28 mgDiscontinuedUnavailableCommercial Changes / Commercial viability12/08/2024
    perindopril erbumineTablet8 mgCurrentLimited AvailabilityManufacturing12/08/2024
    betahistine dihydrochlorideTablet, uncoated16 mgDiscontinuedUnavailableManufacturing12/08/2024
    clopidogrel hydrogen sulfate~aspirinTablet97.87 mg~100 mgCurrentLimited AvailabilityManufacturing12/08/2024
    BevacizumabInjection, concentrated25 mg/mLCurrentLimited AvailabilityCommercial Changes / Commercial viability12/08/2024
    cefaclor monohydrateOral Liquid, powder for26.22 mg/mLCurrentUnavailableManufacturing12/08/2024
    bortezomibInjection, solution3.5 mgCurrentUnavailableManufacturing12/08/2024
    fentanyl citrateInjection, solution157 microgramCurrentLimited AvailabilityManufacturing12/08/2024
    eprosartan mesilateTablet, film coated400 mgDiscontinuedUnavailableManufacturing12/08/2024
    doxycycline monohydrateTablet, uncoated104.1 mgResolvedAvailableManufacturing12/08/2024
    heparin sodiumInjection, solution10 IU/mLAnticipatedAvailableManufacturing12/08/2024
    ketamine hydrochlorideInjection, solution115.3 mg/mLResolvedAvailableManufacturing12/08/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgResolvedAvailableManufacturing12/08/2024
  • 2024.08.12
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    Coxiella burnetiiInjection50 microgram/mLCurrentLimited AvailabilityManufacturing9/08/2024
    lisinopril dihydrateTablet, uncoated10.89 mgCurrentUnavailableManufacturing9/08/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgCurrentLimited AvailabilityManufacturing9/08/2024
    sodium fluorideInjection, concentrated1 mg/mLResolvedAvailableManufacturing9/08/2024
    OmalizumabInjection, solution150 mgCurrentEmergency Supply OnlyManufacturing9/08/2024
    metformin hydrochlorideTablet, modified release1000 mgResolvedAvailableManufacturing9/08/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing9/08/2024
    betahistine dihydrochlorideTablet, uncoated16 mgDiscontinuedUnavailableManufacturing9/08/2024
    acarboseTablet50 mgAnticipatedAvailableManufacturing9/08/2024
    mesalazineTablet, enteric coated800 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues9/08/2024
    ezetimibeTablet, uncoated10 mgAnticipatedAvailableManufacturing9/08/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing9/08/2024
    cinacalcet hydrochlorideTablet66.127 mgCurrentUnavailableManufacturing9/08/2024
    dasatinibTablet, film coated50 mgCurrentUnavailableManufacturing9/08/2024
    escitalopram oxalateTablet, film coated12.74 mgCurrentUnavailableCommercial Changes / Commercial viability9/08/2024
    amlodipine besilate~olmesartan medoxomil~hydrochlorothiazideTablet, film coated6.95 mg~40 mg~25 mgCurrentUnavailableManufacturing9/08/2024
    hydrochlorothiazide~amlodipine besilate~olmesartan medoxomilTablet, film coated12.5 mg~6.95 mg~40 mgCurrentLimited AvailabilityManufacturing9/08/2024
    gefitinibTablet, film coated250 mgCurrentUnavailableProduct recall9/08/2024
    lacosamideTablet, film coated50 mgResolvedAvailableManufacturing9/08/2024
    atovaquone~proguanil hydrochlorideTablet, film coated62.5 mg~25 mgResolvedAvailableManufacturing9/08/2024
    fluoxetine hydrochlorideCapsule, hard22.36 mgResolvedAvailableManufacturing9/08/2024
    cabergolineTablet, uncoated2 mgAnticipatedAvailableManufacturing9/08/2024
    desonideLotion.5 mg/gResolvedAvailableManufacturing9/08/2024
    rizatriptan benzoateWafer14.53 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply9/08/2024
    sodium oxidronateInjection, powder for3.15 mgResolvedAvailableManufacturing9/08/2024
    methylphenidate hydrochlorideTablet, modified release18 mgAnticipatedAvailableManufacturing9/08/2024
    zopicloneTablet, film coated7.5 mgCurrentUnavailableManufacturing9/08/2024
    bicalutamideTablet, film coated50 mgAnticipatedAvailableManufacturing8/08/2024
    adrenaline (epinephrine) acid tartrateInjection, solution182 microgram/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply8/08/2024
    temozolomideCapsule, hard100 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues8/08/2024
    tenofovir disoproxil fumarate~emtricitabineTablet, film coated300 mg~200 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability8/08/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing8/08/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing8/08/2024
    adrenaline (epinephrine) acid tartrateInjection, solution1.819 mgCurrentUnavailableManufacturing8/08/2024
    teriflunomideTablet, film coated14 mgAnticipatedAvailableManufacturing8/08/2024
    olanzapineTablet, uncoated7.5 mgResolvedAvailableManufacturing8/08/2024
    BevacizumabInjection, concentrated25 mg/mLAnticipatedAvailableCommercial Changes / Commercial viability8/08/2024
    sitagliptin fumarateTablet, film coated64.249 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply8/08/2024
    sodium valproateTablet, enteric coated500 mgAnticipatedAvailableManufacturing8/08/2024
    fluorouracilInjection, solution50 mg/mLCurrentLimited AvailabilityManufacturing8/08/2024
    clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand8/08/2024
    nizatidineCapsule, hard300 mgAnticipatedAvailableManufacturing8/08/2024
    roxithromycinTablet, film coated150 mgDiscontinuedUnavailableManufacturing8/08/2024
    roxithromycinTablet, film coated300 mgDiscontinuedUnavailableManufacturing8/08/2024
    framycetin sulfate~gramicidin~dexamethasoneEar Drops5 mg/mL~.05 mg/mL~.5 mg/mLCurrentUnavailableManufacturing7/08/2024
    fluorouracilCream50 mg/gResolvedAvailableManufacturing7/08/2024
    ketorolac trometamolInjection, solution30 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/08/2024
    risperidoneTablet.5 mgCurrentUnavailableManufacturing7/08/2024
    risperidoneTablet1 mgCurrentUnavailableManufacturing7/08/2024
    prochlorperazine maleateTablet5 mgResolvedAvailableManufacturing7/08/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentUnavailableManufacturing7/08/2024
    fentanylDrug delivery system, transdermal10.2 mgDiscontinuedUnavailableCommercial Changes / Commercial viability7/08/2024
    ondansetronTablet, orally disintegrating4 mgResolvedAvailableManufacturing7/08/2024
    mycophenolate mofetilCapsule, hard250 mgDiscontinuedUnavailableManufacturing7/08/2024
    sildenafil citrateTablet, film coated28.1 mgResolvedAvailableManufacturing7/08/2024
    escitalopram oxalateTablet, film coated12.74 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues7/08/2024
    escitalopram oxalateTablet, film coated25.47 mgCurrentUnavailableManufacturing7/08/2024
    AbataceptInjection125.875 mgResolvedAvailableManufacturing7/08/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply7/08/2024
    imatinib mesilateCapsule, hard119.47 mgResolvedAvailableManufacturing7/08/2024
    clonidine hydrochlorideTablet100 microgramAnticipatedAvailableUnexpected increase in consumer demand7/08/2024
    tadalafilTablet, film coated10 mgCurrentUnavailableManufacturing7/08/2024
    tadalafilTablet, film coated20 mgCurrentUnavailableManufacturing7/08/2024
    ephedrine hydrochlorideInjection, solution30 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/08/2024
    nebivolol hydrochlorideTablet5.45 mgResolvedAvailableManufacturing7/08/2024
    tamsulosin hydrochloride~dutasterideCapsule, modified release400 microgram~500 microgramCurrentLimited AvailabilityManufacturing7/08/2024
    hydrocortisone acetateEnema10 % w/wDiscontinuedUnavailableManufacturing7/08/2024
    gramicidin~framycetin sulfate~dexamethasoneEar Drops.05 mg/mL~5 mg/mL~.5 mg/mLCurrentUnavailableManufacturing7/08/2024
    rifampicinCapsule, hard150 mgCurrentUnavailableManufacturing7/08/2024
    eprosartan mesilateTablet, film coated735.8 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/08/2024
    alprostadilInjection, powder for40 microgram/mLCurrentUnavailableManufacturing7/08/2024
    sildenafil citrateTablet, film coated28.09 mgCurrentLimited AvailabilityUnexpected increase in consumer demand6/08/2024
    ramiprilTablet, uncoated5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability6/08/2024
    ramiprilTablet, uncoated10 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability6/08/2024
    isoniazidTablet, uncoated100 mgCurrentUnavailableManufacturing6/08/2024
    prochlorperazine maleateTablet5 mgResolvedAvailableManufacturing6/08/2024
    pramipexole dihydrochloride monohydrateTablet.25 mgResolvedAvailableManufacturing6/08/2024
    oseltamivir phosphateOral Liquid, powder for7.88 mg/mLCurrentEmergency Supply OnlyUnexpected increase in consumer demand6/08/2024
    ropivacaine hydrochlorideInjection, solution400 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues6/08/2024
    trandolaprilCapsule, hard2 mgCurrentLimited AvailabilityManufacturing6/08/2024
    trandolaprilCapsule, hard4 mgCurrentLimited AvailabilityManufacturing6/08/2024
    efmoroctocog alfaInjection, powder for250 IUCurrentUnavailableManufacturing6/08/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply6/08/2024
    tadalafilTablet, film coated20 mgCurrentUnavailableUnexpected increase in consumer demand6/08/2024
    latanoprostEye Drops, solution.05 mg/mLResolvedAvailableManufacturing6/08/2024
    bupivacaine hydrochloride monohydrate~adrenaline (epinephrine) acid tartrateInjection, solution2.64 mg/mL~4.5 microgram/mLCurrentLimited AvailabilityManufacturing6/08/2024
    nebivolol hydrochlorideTablet5.45 mgResolvedAvailableManufacturing6/08/2024
    aciclovirInjection, solution25 mg/mLCurrentUnavailableManufacturing6/08/2024
    iopromideInjection, solution768.86 mg/mLCurrentUnavailableUnexpected increase in consumer demand6/08/2024
    timolol maleateEye Drops, solution6.84 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability6/08/2024
    mianserin hydrochlorideTablet, film coated20 mgCurrentLimited AvailabilityManufacturing6/08/2024
    estradiol~norethisterone acetateDrug delivery system, transdermal.512 mg~4.8 mgCurrentUnavailableManufacturing6/08/2024
    alprostadilInjection, powder for20 microgram/mLCurrentUnavailableManufacturing6/08/2024
    metformin hydrochlorideTablet, film coated500 mgCurrentUnavailableManufacturing6/08/2024
    metformin hydrochlorideTablet, film coated1000 mgCurrentUnavailableManufacturing6/08/2024
    zoledronic acid monohydrateInjection, solution5.33 mgResolvedAvailableManufacturing5/08/2024
    olanzapine pamoate monohydrateInjection, powder for931 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/08/2024
    olanzapine pamoate monohydrateInjection, powder for690 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/08/2024
    olanzapine pamoate monohydrateInjection, powder for483 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/08/2024
    fentanylDrug delivery system, transdermal5.1 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability5/08/2024
    fentanylDrug delivery system, transdermal2.55 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability5/08/2024
    mirtazapineTablet, film coated45 mgAnticipatedAvailableManufacturing5/08/2024
    timolol maleate~dorzolamide hydrochlorideEye Drops, solution6.83 mg/mL~22.26 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability5/08/2024
    pramipexole dihydrochloride monohydrateTablet1 mgResolvedAvailableManufacturing5/08/2024
    pramipexole dihydrochloride monohydrateTablet.125 mgResolvedAvailableManufacturing5/08/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgCurrentLimited AvailabilityManufacturing5/08/2024
    rosuvastatin calcium~ezetimibeTablet~Tablet, film coated10.396 mg~10 mgCurrentLimited AvailabilityManufacturing5/08/2024
    temozolomideCapsule, hard5 mgCurrentUnavailableManufacturing5/08/2024
    rosuvastatin calciumTablet, film coated10.42 mgResolvedAvailableManufacturing5/08/2024
    cefuroxime axetilTablet, film coated300.715 mgCurrentLimited AvailabilityUnexpected increase in consumer demand5/08/2024
    mupirocinOintment20 mg/gResolvedAvailableManufacturing5/08/2024
    alfentanil hydrochlorideInjection, solution1.09 mgResolvedAvailableManufacturing5/08/2024
    montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing5/08/2024
    montelukast sodiumTablet, film coated10.4 mgCurrentLimited AvailabilityUnexpected increase in consumer demand5/08/2024
    mycophenolate mofetilInjection, powder for500 mgCurrentUnavailableManufacturing5/08/2024
    spironolactoneTablet, uncoated100 mgAnticipatedAvailableManufacturing5/08/2024
    flecainide acetateTablet50 mgCurrentUnavailableManufacturing5/08/2024
    indometacinCapsule, hard25 mgCurrentLimited AvailabilityManufacturing5/08/2024
    temozolomideCapsule, hard5 mgAnticipatedAvailableManufacturing5/08/2024
    raltitrexedInjection, powder for2 mgResolvedAvailableUnexpected increase in consumer demand5/08/2024
    captoprilTablet, uncoated25 mgCurrentUnavailableManufacturing5/08/2024
    captoprilTablet, uncoated50 mgCurrentUnavailableManufacturing5/08/2024
    dorzolamide hydrochloride~timolol maleateEye Drops, solution22.26 mg/mL~6.83 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability5/08/2024
    flecainide acetateTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing5/08/2024
    midazolamInjection, solution5 mg/mLCurrentUnavailableManufacturing5/08/2024
  • 2024.08.06
    Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
    prazosin hydrochlorideTablet, uncoated5.476 mgResolvedAvailableUnexpected increase in consumer demand2/08/2024
    fluorouracilCream50 mg/gCurrentLimited AvailabilityManufacturing2/08/2024
    silver sulfadiazineCream10 mg/gCurrentUnavailableManufacturing2/08/2024
    ondansetron hydrochloride dihydrateTablet, film coated5 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues2/08/2024
    emtricitabine~tenofovir disoproxil fumarateTablet, film coated200 mg~300 mgCurrentLimited AvailabilityCommercial Changes / Commercial viability2/08/2024
    dasatinibTablet, film coated100 mgAnticipatedAvailableManufacturing2/08/2024
    atomoxetine hydrochlorideCapsule, hard45.5 mgCurrentLimited AvailabilityManufacturing2/08/2024
    risperidoneOral Liquid, solution1 mg/mLCurrentUnavailableManufacturing2/08/2024
    olmesartan medoxomil~hydrochlorothiazide~amlodipine besilateTablet, film coated40 mg~25 mg~6.95 mgCurrentUnavailableManufacturing2/08/2024
    mycophenolate sodiumTablet, enteric coated384.7 mgAnticipatedAvailableManufacturing2/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgCurrentUnavailableManufacturing2/08/2024
    olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~13.88 mgCurrentLimited AvailabilityManufacturing2/08/2024
    erythromycin ethyl succinateOral Liquid, powder for468 mgAnticipatedAvailableUnexpected increase in consumer demand2/08/2024
    heparin sodiumInjection, solution10 IU/mLAnticipatedAvailableManufacturing2/08/2024
    sodium lactate~icodextrin~magnesium chloride hexahydrate~calcium chloride dihydrate~sodium chlorideSolution, dialysis4.5 g/L~75 g/L~51 mg/L~257 mg/L~5.4 g/LCurrentLimited AvailabilityManufacturing2/08/2024
    medroxyprogesterone acetateInjection, suspension150 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability1/08/2024
    gliclazideTablet, modified release30 mgCurrentUnavailableManufacturing1/08/2024
    levetiracetamTablet, film coated250 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues1/08/2024
    enalapril maleateTablet10 mgCurrentUnavailableManufacturing1/08/2024
    duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing1/08/2024
    tadalafilTablet, film coated20 mgCurrentLimited AvailabilityManufacturing1/08/2024
    rizatriptan benzoateTablet, orally disintegrating14.53 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues1/08/2024
    tranexamic acidInjection, solution1000 mgAnticipatedAvailableCommercial Changes / Commercial viability1/08/2024
    chromium(51Cr) edetateInjection, solution8 MBq/mLCurrentUnavailableManufacturing1/08/2024
    desvenlafaxine benzoateTablet, modified release73.16 mgResolvedAvailableManufacturing1/08/2024
    cefepime hydrochloride monohydrateInjection, powder for2378.5 mgCurrentLimited AvailabilityManufacturing1/08/2024
    ribavirinTablet, film coated200 mgDiscontinuedReduction in supply until supply is exhaustedManufacturing1/08/2024
    ezetimibeTablet, uncoated10 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply1/08/2024
    imatinib mesilateCapsule, hard119.47 mgAnticipatedAvailableManufacturing1/08/2024
    dosulepin (dothiepin) hydrochlorideCapsule, hard25 mgAnticipatedAvailableManufacturing1/08/2024
    gliclazideTablet, modified release30 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply1/08/2024
    cinacalcet hydrochlorideTablet, film coated66 mgCurrentUnavailableManufacturing1/08/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~82.725 mgCurrentUnavailableManufacturing1/08/2024
    modafinilTablet, uncoated100 mgCurrentLimited AvailabilityManufacturing1/08/2024
    lurasidone hydrochlorideTablet, film coated80 mgCurrentUnavailableManufacturing1/08/2024
    lurasidone hydrochlorideTablet, film coated40 mgCurrentUnavailableManufacturing1/08/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.8 mgCurrentLimited AvailabilityManufacturing1/08/2024
    larotrectinib sulfateOral Liquid, solution24.6 mg/mLResolvedAvailableManufacturing1/08/2024
    heparin sodiumInjection, solution1000 IU/mLCurrentUnavailableManufacturing1/08/2024
    doxycycline monohydrateTablet, uncoated104.1 mgCurrentLimited AvailabilityManufacturing1/08/2024
    sodium pertechnetate(99mTc)Injection, solution20 GBqCurrentLimited AvailabilityManufacturing1/08/2024
    sodium pertechnetate(99mTc)Injection370 GBqCurrentLimited AvailabilityManufacturing1/08/2024
    baclofenTablet, uncoated10 mgResolvedAvailableManufacturing1/08/2024
    ethosuximideCapsule, soft250 mgCurrentUnavailableManufacturing1/08/2024
    duloxetine hydrochlorideCapsule, enteric67.3 mgAnticipatedAvailableManufacturing31/07/2024
    griseofulvinTablet, uncoated125 mgCurrentUnavailableManufacturing31/07/2024
    olanzapineTablet, uncoated7.5 mgResolvedAvailableManufacturing31/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~5.198 mgCurrentLimited AvailabilityManufacturing31/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~20.791 mgResolvedAvailableManufacturing31/07/2024
    entecavirTablet, film coated1 mgCurrentUnavailableManufacturing31/07/2024
    oxycodone hydrochlorideCapsule, hard10 mgCurrentUnavailableCommercial Changes / Commercial viability31/07/2024
    rosuvastatin calciumTablet, film coated5.21 mgCurrentLimited AvailabilityManufacturing31/07/2024
    emtricitabine~tenofovir disoproxil maleateTablet, film coated200 mg~300 mgCurrentLimited AvailabilityManufacturing31/07/2024
    mercaptopurine monohydrateTablet50 mgCurrentLimited AvailabilityManufacturing31/07/2024
    ketorolac trometamolInjection, solution30 mg/mLCurrentUnavailableManufacturing31/07/2024
    Avalglucosidase alfaInjection, powder for100 mgResolvedAvailableManufacturing31/07/2024
    lanreotide acetateInjection, solution133.33 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues31/07/2024
    ezetimibe~rosuvastatin calciumTablet10 mg~10.4 mgCurrentLimited AvailabilityManufacturing31/07/2024
    rifampicinCapsule, hard150 mgCurrentUnavailableManufacturing31/07/2024
    clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand31/07/2024
    varenicline tartrate~varenicline tartrateTablet, film coated.85 mg~1.71 mgCurrentUnavailableManufacturing30/07/2024
    varenicline tartrateTablet, film coated1.71 mgCurrentUnavailableManufacturing30/07/2024
    risperidoneTablet, film coated2 mgCurrentUnavailableManufacturing30/07/2024
    albendazoleTablet, chewable400 mgResolvedAvailableCommercial Changes / Commercial viability30/07/2024
    salbutamol sulfateInhalation, conventional3 mgCurrentUnavailableManufacturing29/07/2024
    sodium pertechnetate(99mTc)Injection, solution18.5 GBqCurrentUnavailableManufacturing29/07/2024
    paliperidoneTablet, modified release6 mgResolvedAvailableManufacturing29/07/2024
    SomatropinInjection, powder for12 mg/mLResolvedAvailableUnexpected increase in consumer demand29/07/2024
    donepezil hydrochlorideTablet, film coated5 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues29/07/2024
    omeprazoleCapsule20 mgCurrentLimited AvailabilityManufacturing29/07/2024
    drospirenone~ethinylestradiolTablet3 mg~30 microgramResolvedAvailableManufacturing29/07/2024
    trandolaprilCapsule, hard.5 mgCurrentLimited AvailabilityManufacturing29/07/2024
    trandolaprilCapsule, hard1 mgAnticipatedAvailableManufacturing29/07/2024
    OmalizumabInjection, solution150 mgCurrentEmergency Supply OnlyManufacturing29/07/2024
    quetiapine fumarateTablet, film coated345.36 mgAnticipatedAvailableManufacturing29/07/2024
    adefovir dipivoxilTablet10 mgCurrentUnavailableUnexpected increase in consumer demand29/07/2024
    temozolomideCapsule, hard180 mgAnticipatedAvailableManufacturing29/07/2024
    rosuvastatin calciumTablet, film coated41.68 mgCurrentUnavailableCommercial Changes / Commercial viability29/07/2024
    potassium clavulanate~amoxicillin trihydrateTablet, film coated148.875 mg~1006.25 mgCurrentUnavailableManufacturing29/07/2024
    mesalazineTablet, enteric coated800 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues29/07/2024
    tadalafilTablet5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply29/07/2024
    tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing29/07/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand29/07/2024
    cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand29/07/2024
    ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~41.363 mgCurrentUnavailableManufacturing29/07/2024
    atorvastatin calcium trihydrate~ezetimibeTablet, film coated41.363 mg~10 mgCurrentUnavailableManufacturing29/07/2024
    dimethyl fumarateCapsule, enteric240 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues29/07/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentLimited AvailabilityManufacturing29/07/2024
    nebivolol hydrochlorideTablet5.45 mgCurrentUnavailableManufacturing29/07/2024
    mesalazineTablet, enteric coated1.6 gAnticipatedAvailableTransport / Logistic issues / Storage capacity issues29/07/2024
    lacosamideTablet, film coated50 mgCurrentUnavailableManufacturing29/07/2024
    mycophenolate mofetilSuspension200 mg/mLCurrentLimited AvailabilityManufacturing29/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated109 mgCurrentUnavailableManufacturing29/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated54.5 mgCurrentUnavailableManufacturing29/07/2024
    sitagliptin hydrochloride monohydrateTablet, film coated27.25 mgCurrentUnavailableManufacturing29/07/2024
    ezetimibe~rosuvastatin calciumTablet~Tablet, film coated10 mg~41.6 mgCurrentUnavailableManufacturing29/07/2024
    norethisterone acetate~estradiolDrug delivery system, transdermal2.7 mg~.62 mgCurrentUnavailableManufacturing29/07/2024
    baclofenTablet10 mgResolvedAvailableManufacturing29/07/2024

ドイツ

  • 2024.08.23
    有効成分投与形態理由最後のメッセージの日付
    ノナコグ・ベータ・ペゴルパウダーerung 生産能力が予想を下回ったため22.08.2024
    トロクトコグ アルファパウダーerung 生産能力が予想を下回ったため22.08.2024
    アジスロマイシン二水和物フィルムコート錠一次包装の在庫不足。22.08.2024
    メトホルミン塩酸塩;シタグリプチン塩酸塩一水和物フィルムコート錠これ以上の情報はない22.08.2024
    オフロキサシン目薬該当なし22.08.2024
    フルオロメトロン目薬該当なし22.08.2024
    メサラジン徐放性有効成分含有錠剤該当なし22.08.2024
    クロラムフェニコール眼軟膏該当なし22.08.2024
    アジスロマイシン二水和物フィルムコート錠該当なし21.08.2024
    アモキシシリン三水和物タブレット該当なし21.08.2024
    ヒドロモルフォン塩酸塩徐放錠該当なし21.08.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠該当なし21.08.2024
    アジスロマイシン二水和物フィルムコート錠該当なし21.08.2024
    プロピオン酸クロベタゾール(Ph.Eur.)Lung該当なし21.08.2024
    硫酸ゲンタマイシン眼軟膏該当なし21.08.2024
    デキサメタゾン;硫酸ゲンタマイシン眼軟膏該当なし21.08.2024
    硫酸サルブタモール加圧ガスの吸入ALBVVGは経済的な継続を保証するものではない。20.08.2024
    デキサメタゾンリン酸二水素二ナトリウム(Ph.Eur.)Injektionslung該当なし20.08.2024
    アモキシシリン三水和物フィルムコート錠該当なし20.08.2024
    クリンダマイシン塩酸塩一水和物ハードカプセル該当なし20.08.2024
    塩酸バンコマイシンハードカプセル競合他社の在庫切れにより、12月と1月にerhteの販売が好調だった。20.08.2024
    オランザピンエンボン酸一水和物パウダー供給ボトルネックの原因は、針の供給問題である。19.08.2024
    イバンドロン酸ナトリウム一水和物フィルムコート錠Erhte アレンドロン舫の配送ボトルネックによる需要19.08.2024
    リセドロン酸ナトリウム-219.08.2024
    ポサコナゾール経口懸濁液調製用粉末Erhte 需要19.08.2024
    エゼチミブタブレット該当なし19.08.2024
    塩化ミバキュリウムInjektionslung該当なし19.08.2024
    塩酸プリロカインInjektionslung該当なし19.08.2024
    塩酸ミノサイクリン((無水19.08.2024
    メタミゾールナトリウム一水和物Injektionslung供給されたアンプルの品質問題19.08.2024
    ヒドロモルフォン塩酸塩徐放錠該当なし16.08.2024
    フェンプロクーモンタブレット該当なし15.08.2024
    パルミチン酸レチノール経口ドロップ該当なし15.08.2024
    トピラマートフィルムコート錠該当なし15.08.2024
    フォスカルネットナトリウム六水和物Infusionslung該当なし15.08.2024
    ノナコグ・ベータ・ペゴルパウダーerung 生産能力が予想を下回ったため15.08.2024
    オクスカルバゼピン徐放性有効成分含有錠剤該当なし15.08.2024
    オクスカルバゼピン経口懸濁液該当なし15.08.2024
    イトラコナゾールハードカプセル該当なし14.08.2024
    クラリスロマイシン経口懸濁液調製用顆粒該当なし14.08.2024
    アジスロマイシン二水和物フィルムコート錠該当なし14.08.2024
    トロクトコグ・アルファ・ペゴルInjektionslung 調製用粉末erung 生産能力が予想を下回ったため14.08.2024
    ブプレノルフィン経皮吸収パッチ該当なし14.08.2024
    シクロピロックス・オラミンL、皮膚に塗布する。該当なし13.08.2024
    アニデュラファンギン粉末・・・輸液用濃縮液ung該当なし13.08.2024
    ブプレノルフィン経皮吸収パッチ該当なし13.08.2024
    ヒドロモルフォン塩酸塩徐放錠該当なし13.08.2024
    アトモキセチン塩酸塩ハードカプセル該当なし13.08.2024
    ベタメタゾン・バレレート(Ph.Eur.)エマルジョン該当なし13.08.2024
    ノナコグ・ガンマパウダー該当なし12.08.2024
    塩酸レミフェンタニル粉末・・・注射剤/輸液用濃縮液ung該当なし12.08.2024
    エピネフリン酒石酸水素塩/アドレナリン酒石酸水素塩;プリロカイン塩酸塩Injektionslung該当なし12.08.2024
    アバカビル塩酸塩;ラミブジンフィルムコート錠該当なし12.08.2024
    アモキシシリン三水和物経口懸濁液調製用粉末該当なし12.08.2024
    塩酸ブプレノルフィン舌下錠該当なし12.08.2024
  • 2024.08.12
    有効成分投与形態理由メッセージの種類最後のメッセージの日付
    塩酸メチルフェニデート徐放錠その他変更通知11.08.2024
    クエン酸スフェンタニルInjektionslung生産における問題最初の通知09.08.2024
    タクロリムス一水和物軟膏生産における問題変更通知08.08.2024
    インスリン・デグルデクInjektionslung最終リリースの問題点最初の通知08.08.2024
    トロクトコグ アルファパウダー生産能力不足最初の通知08.08.2024
    フェンプロクーモンタブレット生産における問題変更通知08.08.2024
    セマグルチドInjektionslungErhte 需要最初の通知08.08.2024
    カルバマゼピン徐放錠その他変更通知07.08.2024
    塩酸メルペロンフィルムコート錠生産能力不足変更通知07.08.2024
    フルオロウラシルInjektionslung生産における問題変更通知07.08.2024
    リセドロン酸ナトリウム-2変更通知07.08.2024
    リスペリドンフィルムコート錠生産における問題変更通知07.08.2024
    ブプレノルフィン経皮吸収パッチErhte 需要最初の通知07.08.2024
    アザシチジン注射懸濁液調製用粉末その他最初の通知07.08.2024
    ブプレノルフィン経皮吸収パッチErhte 需要最初の通知07.08.2024
    アトモキセチン塩酸塩ハードカプセルその他最初の通知07.08.2024
    ブプレノルフィン経皮吸収パッチErhte 需要変更通知07.08.2024
    アトモキセチン塩酸塩ハードカプセルその他最初の通知07.08.2024
    クリンダマイシン塩酸塩一水和物ハードカプセルErhte 需要変更通知07.08.2024
    アモキシシリン三水和物フィルムコート錠Erhte 需要変更通知07.08.2024
    セファドロキシル一水和物経口懸濁液調製用粉末Erhte 需要変更通知07.08.2024
    カルボプラチンInfusionsl調製用濃縮液ungその他最初の通知06.08.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題変更通知06.08.2024
    レベチラセタムフィルムコート錠生産における問題変更通知06.08.2024
    ラモトリギンタブレット生産における問題変更通知06.08.2024
    フォスカルネットナトリウム六水和物Infusionslungその他最初の通知06.08.2024
    ヒドロモルフォン塩酸塩徐放錠Erhte 需要変更通知06.08.2024
    メトプロロール酒石酸塩(Ph.Eur.)徐放錠Erhte 需要変更通知06.08.2024
    塩酸シナカルセスフィルムコート錠Erhte 需要変更通知06.08.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠Erhte 需要変更通知06.08.2024
    アモキシシリン三水和物フィルムコート錠Erhte 需要変更通知06.08.2024
    モメタゾンフロエート(Ph.Eur.)軟膏生産能力不足最初の通知06.08.2024
    メシル酸ラサギリンタブレット生産における問題変更通知06.08.2024
    フルニソリド半水和物鼻腔スプレー生産能力不足変更通知06.08.2024
    <2>シプロフロキサシン塩酸塩(1:1) 1 H Oフィルムコート錠Erhte 需要変更通知06.08.2024
    アモキシシリン三水和物タブレットErhte 需要変更通知06.08.2024
    メサラジン腸溶性フィルムコーティング錠Erhte 需要最初の通知05.08.2024
    フェノキシメチルペニシリンカリウム経口用 Lung 調製用粉末Erhte 需要変更通知05.08.2024
    セファクロル一水和物ハードカプセル生産能力不足変更通知05.08.2024
    フェノキシメチルペニシリンカリウム経口用L製剤用顆粒ungErhte 需要変更通知05.08.2024
    ヒドロクロロチアジド;塩酸キナプリルフィルムコート錠その他変更通知05.08.2024
    塩酸キナプリルフィルムコート錠その他変更通知05.08.2024
    ヒドロコルチゾン-17-ブタン酸エステルL、皮膚に塗布する。Erhte 需要最初の通知05.08.2024
    ラモトリギン経口懸濁液調製用錠剤生産能力不足変更通知05.08.2024
    ウラピジルハードカプセル他メーカーとの問題変更通知05.08.2024
    硫酸サルブタモール加圧ガスの吸入その他変更通知05.08.2024
    イトラコナゾールハードカプセルその他変更通知05.08.2024
    クリンダマイシン塩酸塩一水和物ハードカプセルErhte 需要変更通知05.08.2024
    エゼチミブタブレットErhte 需要変更通知05.08.2024
    塩酸レボメタドンタブレットその他変更通知05.08.2024
    塩酸ブプレノルフィン舌下錠生産における問題変更通知05.08.2024
    葉酸カルシウム変更通知05.08.2024
  • 2024.08.06
    有効成分投与形態理由メッセージの種類最後のメッセージの日付
    葉酸カルシウム変更通知05.08.2024
    ジプロピオン酸ベタメタゾン(Ph.Eur.);サリチル酸舫レL、皮膚に塗布する。生産能力不足変更通知02.08.2024
    アトモキセチン塩酸塩ハードカプセル生産における問題最初の通知02.08.2024
    ペリンドプリル-tert-ブチルアミンタブレットErhte 需要最初の通知02.08.2024
    トラゾドン塩酸塩タブレット生産能力不足最初の通知02.08.2024
    リザトリプタン安息香酸塩タブレット生産における問題変更通知02.08.2024
    リザトリプタン安息香酸塩溶解タブレット生産における問題変更通知02.08.2024
    フマル酸クエチアピン(欧州製薬)徐放錠生産における問題変更通知02.08.2024
    エゼチミブ; シンバスタチンタブレットバッチテストの問題点変更通知02.08.2024
    ブプレノルフィン経皮吸収パッチ生産における問題変更通知02.08.2024
    オランザピンエンボン酸一水和物パウダーその他最初の通知01.08.2024
    モメタゾンフロエート(Ph.Eur.)L、皮膚に塗布する。生産能力不足最初の通知01.08.2024
    トロクトコグ アルファパウダー生産能力不足最初の通知01.08.2024
    酢酸メドロキシプロゲステロンタブレットその他最初の通知01.08.2024
    カンデサルタンシレキセチルタブレットその他変更通知01.08.2024
    カルバマゼピン該当なし変更通知31.07.2024
    塩酸プロプラノロールハードカプセル生産能力不足最初の通知30.07.2024
    ナロキソン塩酸塩二水和物;オキシコドン塩酸塩(Ph.Eur.)徐放錠生産能力不足変更通知30.07.2024
    インスリン グラルギンInjektionslung他メーカーとの問題変更通知30.07.2024
    ジヒドロコデイン[(R変更通知29.07.2024
    硫酸ゲンタマイシン目薬生産における問題変更通知29.07.2024

フランス

  • 2024.08.20
    在庫切れ2024年8月19日マイコスタチン 100 000 IU/ml、経口懸濁液 – [ナイスタチン]
    継続中2024年8月12日ミダゾラムビアトリス5mg/ml、注射用または直腸用溶液 – [ミダゾラム]
    供給の緊張2024年8月12日アミカシンビアトリス250mg、500mg及び1g、バイアル入り注射用粉末製剤 – [アミカシン(硫酸塩)
  • 2024.08.12
    ステータスアップデートスペシャリティ
    供給の緊張2024年8月9日アルベスコ80μg/回・160μg/回加圧吸入液 – [シクレソニド]
    供給の緊張2024年8月9日ロバルサイト 50mg/ml、経口液用粉末 – [バルガンシクロビル]
    供給の緊張2024年8月9日イリノテカンサン 1.5mg/ml、輸液(イリノテカン(塩酸塩)三水和物)
    供給の緊張2024年8月9日ブリカニール0.5mg/1ml、アンプル入り注射用溶液 – [テルブタリン(硫酸塩)
    在庫切れ2024年8月8日イカティバント・ビアトリス 30mg、プレフィルドシリンジ注射液 – [イカティバント(酢酸塩)
    回復2024年8月8日プレギゾール、バッグ入り冠動脈内投与用心筋保護液 – [カルシウム(塩化物)二水和物/マグネシウム(塩化物)六水和物/カリウム(塩化物)/ナトリウム(塩化物]
    供給の緊張2024年8月8日リスペリドンL.P. 37.5mg/2mL、プレフィルドシリンジ注射用徐放性懸濁液の粉末および溶剤 – [リスペリドン]
    供給の緊張2024年8月7日ヘパリンカルシウム25 000 IU/mL、0.2 mL及び0.3 mLのプレフィルドシリンジ(S.C.)中の注射用溶液、カルシパリン5 000 IU/0.2mL及び7 500 IU/0.3mL、プレフィルドシリンジ(S.C.)中の注射用溶液-[ヘパリンカルシウム]。
    供給の緊張2024年8月7日ミダゾラム ビアトリス 5mg/ml、注射用または直腸用溶液 – [ミダゾラム]
    供給の緊張2024年8月7日アスペジック注射用500mg/5ml、非経口用粉末・溶液-[アセチルサリチル酸リジン]
    在庫切れ2024年8月6日クラベンチン 3g/200mg、5g/200mg、注射用粉末(I.V.) – [チカルシリン(ナトリウム)、クラブラン酸]
    供給の緊張2024年8月6日フルオレセインフォーレ0.5% 1回量容器入り点眼液 – [フルオレセインナトリウム]
    供給の緊張2024年8月6日ベビチン100mg/2mlおよび500mg/10ml、アンプル入り注射用溶液-[チアミン塩酸塩]。
    在庫切れ2024年8月5日バイパーファブ、輸液用希釈液 – [ヨーロッパ毒蛇抗毒素免疫グロブリンウマF(ab’)2フラグメント]
    供給の緊張2024年8月5日リタリンLP 20mg、30mg、40mg徐放カプセル – [塩酸メチルフェニデート
    供給の緊張2024年8月5日コンサータLP、徐放錠 – [塩酸メチルフェニデート] (メチルフェニデート)
    回復2024年8月5日フルオロウラシル・アコード 50mg/ml、希釈可能輸液、5ml、20ml、100mlバイアル – [フルオロウラシル]
  • 2024.08.06
    ステータス (英語)アップデートスペシャルティ
    供給の緊張2024年8月2日ミバクロン20mg/10ml、注射用液(静注) – [ミバクリウム塩化物]
    供給の緊張2024年8月2日Mydriaticum 2mg/0.4ml、1回量容器入り点眼薬 – [tropicamide]
    供給の緊張2024年8月2日アンアルファ 1μg/0.5ml、アンプル入り静注用溶液 – [アルファカルシドール]
    在庫切れ2024年8月1日アカルボース50mg(医療用医薬品)-[アカルボース]
    供給の緊張2024年8月1日バルプロ酸ナトリウム・L.P. 500 mg、長時間作用型ペリキュラー製剤 – (バルプロ酸ナトリウム)
    在庫切れ2024年8月1日フルオロウラシル テバ 50mg/ml、輸液用希釈液、100mlバイアル – [フルオロウラシル]
    在庫切れ2024年8月1日フルオロウラシル テバ 50mg/ml、輸液用希釈液、20mlバイアル – [フルオロウラシル]
    在庫切れ2024年8月1日キシロカイン20mg/ml アドレナリン0.005mg/ml、注射用溶液 – [リドカイン-アドレナリン]
    供給の緊張2024年8月1日チアプリダール100mg/2ml、注射用液 – [チアプリド(塩酸塩)
    在庫切れ2024年8月1日コリジェンタAP-HP 27mg – 50mg小児用カプセル – [コリスチン、ゲンタマイシン]
    在庫切れ2024年8月1日エトポシド・テバ20mg/ml、希釈輸液用溶液-[エトポシド]
    販売中止2024年7月31日メトトレキサート・テバ10%、注射用溶液 – [メトトレキサート]
    供給の緊張2024年7月31日リスペリドンL.P. 37.5mg/2mL、プレフィルドシリンジ注射用徐放性懸濁液用粉末および溶剤 – [risperidone]
    在庫切れ2024年7月31日エトポシド・アコード 20mg/ml、輸液用希釈液 – [エトポシド]
    供給の緊張2024年7月30日ノボエイト2000IU注射液用粉末・溶剤 – [ツロクトコグ アルファ] [ツロクトコグ アルファ
    在庫切れ2024年7月30日メトトレキサート・アコード 100mg/mL 点滴用希釈液 – [メトトレキサート]
    在庫切れ2024年7月30日オンダンセトロン アコード 2 mg/ml、注射用溶液 – [オンダンセトロン]
    供給の緊張2024年7月30日免疫グロブリン点滴静注用・SC用(ベース) – [免疫グロブリン点滴静注用(IgG)
    在庫切れ2024年7月30日ゾフレン2mg/ml、注射用アンプル(静注用)2mlおよび4mlアンプル – [オンダンセトロン]
    供給の緊張2024年7月29日ペガシス90μg、135μg、180μg注射液(プレフィルドシリンジ) – [peginterferon alfa-2a
    在庫切れ2024年7月29日アンアルファ 2μg/1ml、アンプル入り静注用溶液 – [アルファカルシドール]
    供給の緊張2024年7月29日トフラニール 10mg、コーティング錠 – [イミプラミン]

英国

EU

EUの情報はありません。

このページの先頭へ戻る